Airbus bags 300 airliners order from China, surpasses rival Boeing
Category: #headlines  By Nikita Chaurasia  Date: 2019-03-28
  • share
  • Twitter
  • Facebook
  • LinkedIn

Airbus bags 300 airliners order from China, surpasses rival Boeing

Owing to surging travel demand, China has become a key competing ground for Airbus and its chief rival Boeing.
Airbus, one of the leading names in the aerospace sector, recently signed a multibillion-dollar deal to sell 300 airliners to China. With this, it has equaled the Chinese record held by arch-rival Boeing. The deal apparently coincided with the Chinese President, Xi Jinping’s Europe visit.

The deal was made between Airbus and Chinese Aviation Supplies Holding Company, which is known to grab headlines during such diplomatic visits. The deal has been reported by Fortune to include 290 A-320 family jets and ten A-350 wide-body jets.

This extraordinary order is equivalent with the U.S. President Donald Trump’s order for 300 Boeing Planes in 2017 when he was visiting Beijing. Amid the global trading tensions, China had refrained from placing any significant orders in the aviation industry.

Apart from this, it is also cited that the sudden grounding of Boeing 737 Max has created a dearth of major orders for the aircraft manufacturing company.

Although there is no concrete proof of the direct connection of Airbus deal and Sino-US stiffness or the Boeing fleet issues, experts opine that Beijing is well-known for its practice of giving diplomatic responses and disappointing suppliers via state deals.

Emmanuel Macron, French President along with Chinese counterpart Xi Jinping jointly addressed the closure of the aviation contract and said that this is a vital step forward and an excellent indicator of the current scenario. With this, US and China have enhanced the likely possibility to ease out the months-long tariff row.

For the record, China became the first country to ground aviation of Boeing 737 model in March-beginning when a disastrous Ethiopian Airlines crash stunned the world, thus imposing severe regulatory actions. Sources close to the matter report that on enquiry about deal negotiations, Airbus planemaking chief, Guillaume Faury clarified that it was a long-term relationship that has evolved over time with Chinese partners and is a strong indicator of confidence.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
By Nikita Chaurasia

Tmunity Therapeutics Inc., a clinical-stage biotherapeutics firm focused on advanced T-cell immunotherapy, has reportedly dosed the first patient in its Phase 1 CART-TnMUC1-01 clinical trial with TnMUC1 (Tn/STn glycoform of mucin 1) CAR-T (chimeric a...

Hyundai and Uber team up to develop all-electric flying taxis
Hyundai and Uber team up to develop all-electric flying taxis
By Nikita Chaurasia

In the midst of technological advancements increasing at a commendable pace, Uber’s flying taxi initiative seems to be edging closer to reality – the reality of establishing flying cars in the near future. The ride-hailing giant has appar...

BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
By Nikita Chaurasia

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging artificial intelligence approaches to advance the next wave of medicines in immuno-oncology and neuroscience, has reportedly announced the initiation of its SERENITY progr...